Liver MRI: From basic protocol to advanced techniques. Issue 93 (August 2017)

• Record Type: Journal Article
• Authors: Donato, Henrique; França, Manuela; Candelária, Isabel; Caseiro-Alves, Filipe
• Is Part Of: European journal of radiology. Issue 93(2017)
• Page Start: 30
• Page End: 39
• Publication Date: 2017-08
• Subjects: MRI -- Liver -- Diffusion MRI -- Perfusion imaging -- Fatty liver -- Liver cirrhosis; Medical radiology -- Periodicals; Radiology -- Periodicals; Radiologie médicale -- Périodiques; Medical radiology; Periodicals; 616.075705
• DOI: 10.1016/j.ejrad.2017.05.028
• Languages: English
• ISSNs: 0720-048X

Abstract

Highlights: Liver MR is a well-established multiparametric imaging modality. Standard protocol includes T1, T2, diffusion and contrast-enhanced sequences. High field strength (3T) exams require adaptations to the imaging protocol. Advanced MR techniques can give new valuable information. Abstract: Liver MR is a well-established modality with multiparametric capabilities. However, to take advantage of its full capacity, it is mandatory to master the technique and optimize imaging protocols, apply advanced imaging concepts and understand the use of different contrast media. Physiologic artefacts although inherent to upper abdominal studies can be minimized using triggering techniques and new strategies for motion control. For standardization, the liver MR protocol should include motion-resistant T2-w sequences, in-op phase GRE T1 and T2-w fast spin echo sequences with fat suppression. Diffusion-weighted imaging (DWI) is mandatory, especially for detection of sub-centimetre metastases. Contrast-enhanced MR is the cornerstone of liver MR, especially for lesion characterization. Although extracellular agents are the most extensively used contrast agents, hepatobiliary contrast media can provide an extra-layer of functional diagnostic information adding to the diagnostic value of liver MR. The use of high field strength (3T) increases SNR but is more challenging especially concerning artefact control. Quantitative MR belongs to the new and evolving field of radiomics where the use of emerging biomarkers such as perfusion or DWI can derive new information regarding disease detection, prognostication and evaluation of tumour response. This information can overcome some of the limitations of current tests, especially when using vascular disruptive agents for oncologic treatment assessment. MR is, today, a robust, mature, multiparametric imaging modality where clinical applications have greatly expanded from morphology to advanced imaging. This new concept should be acknowledged by all those involved in producing high quality, high-end liver MR studies.